FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · CNN — The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this...
FluMist approved for self-administration in the US - astrazeneca.com
Sep 20, 2024 · FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L) nasal spray flu vaccine for self-administration, making it the first of its...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
Sep 20, 2024 · “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with...
FDA approves first self-administered flu vaccine spray - CBS News
Sep 20, 2024 · The FDA says patients will still need to get a prescription for the vaccine from a health care provider. AstraZeneca says it plans to sell FluMist directly to patients through an online...
FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
Sep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1
FDA approves first at-home flu vaccine in U.S., a nasal spray
Sep 20, 2024 · The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration.
Nasal Flu Vaccine Is Approved for At-Home Use
Sep 20, 2024 · The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have easy access to a nasal spray vaccine that is potentially lifesaving.
Next season, you may be able to take your flu vaccine at home
Oct 24, 2023 · The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday. The...
Nasal Flu Vaccine FluMist Gets FDA Approval for At-Home Use
Oct 4, 2024 · Recently, the Food and Drug Administration (FDA) removed those obstacles by approving the at-home use of FluMist®, an influenza vaccine administered by nasal spray. Made by AstraZeneca, FluMist will be available for home use starting in the fall of 2025.